Logotyp: till Uppsala universitets webbplats

uu.sePublikationer från Uppsala universitet
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Patient safety of adjunct pre-operative intravenous S-ketamine for pain relief in third molar surgery: a randomised, placebo-controlled, double-blind trial
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Centrum för klinisk forskning Dalarna. Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kirurgiska vetenskaper.ORCID-id: 0009-0002-1818-7347
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kirurgiska vetenskaper.ORCID-id: 0000-0003-1454-3148
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kirurgiska vetenskaper, Anestesiologi och intensivvård.ORCID-id: 0000-0003-3923-4093
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kirurgiska vetenskaper.ORCID-id: 0000-0001-9590-2039
Visa övriga samt affilieringar
2024 (Engelska)Ingår i: BRITISH JOURNAL OF PAIN, ISSN 2049-4637, Vol. 18, nr 6, s. 450-460Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Purpose

To study patient safety in third molar surgery, where two different doses of S-ketamine were administered for pain relief and compared to a placebo (saline). The primary focus was capillary oxygen saturation of the blood (SpO2) and secondarily, alterations in respiratory rate, blood pressure, pulse or adverse events.

Methods

One hundred and sixty-eight subjects were included in a randomised, placebo-controlled, double-blind trial. The two subanaesthetic study drugs were low-dose S-ketamine (0.125 mg/kg) and high-dose S-ketamine (0.25 mg/kg). Every patient was sedated with midazolam prior to infusion of the investigational drug. The teeth were surgically removed according to a routine clinical procedure, under local anaesthesia.

Results

Primary end-point for the safety aspects was capillary oxygen saturation (SpO2) after administration of the investigational drug was finished. A significant difference was found between the placebo and the high-dose group at that point (p = .021), with a decrease of saturation in the high-dose group. The lowest saturation and the number of registrations of SpO2 <90% did not show any difference between groups. Oxygen supplementation was given in circa 40% of the cases with no differences between the intervention groups. No other significant differences between groups regarding saturation or respiratory rate were noted.

Conclusion

In this study, it was safe to use adjunct preoperative single-dose intravenous S-ketamine 0.25 mg/kg body weight for pain relief, in midazolam-sedated patients receiving third molar surgery. There were no serious adverse events or symptoms of overdose nor any clinically relevant effects on circulatory or respiratory parameters.

Ort, förlag, år, upplaga, sidor
Sage Publications, 2024. Vol. 18, nr 6, s. 450-460
Nyckelord [en]
Adverse events, physiological effects, safety, S-ketamine
Nationell ämneskategori
Anestesi och intensivvård
Identifikatorer
URN: urn:nbn:se:uu:diva-547724DOI: 10.1177/20494637241262509ISI: 001251606000001PubMedID: 39552919OAI: oai:DiVA.org:uu-547724DiVA, id: diva2:1934574
Forskningsfinansiär
Region DalarnaTillgänglig från: 2025-02-04 Skapad: 2025-02-04 Senast uppdaterad: 2025-10-09Bibliografiskt granskad
Ingår i avhandling
1. A clinical trial of S-ketamine analgesia in third molar surgery: Effects, safety and influence on inflammatory biomarkers
Öppna denna publikation i ny flik eller fönster >>A clinical trial of S-ketamine analgesia in third molar surgery: Effects, safety and influence on inflammatory biomarkers
2025 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Background and aims: Third molar surgery is a common surgical procedure and a well-established pain model in research, which is generally performed under local anaesthesia. Post-operative pain management is often solved with a combination of paracetamol and ibuprofen. In this thesis, our goal was to find a better alternative for pain management in the early post-operative period.  The overall aim was to study if preoperative IV S-ketamine (0.125mg/kg or 0.25mg/kg) can offer a more effective and safer transition from local anaesthesia to orally administered analgesia, to investigate whether surgery or S-ketamine have an impact on inflammatory biomarkers in plasma, and to examine differences in protein expression between saliva and plasma. 

Patients and methods: 168 patients participated in the study. Physiological variables, questionnaires, pain diaries, and self-reported side effects were all registered in the study. Biomarkers in plasma and saliva were analysed using a multiplex panel (Olink).

Results: There was a globally significant lower pain score in the group with high dose S-ketamine, and a longer time to first rescue medication. There were minor, clinically insignificant changes of SpO2 and pulse rate in the S-ketamine 0.25 mg/kg group.  Surgery significantly affected certain biomarkers (IL6, CST5, OSM, TGF-alpha, IL10, FGF-19, Flt3L, white blood cell count, neutrophil blood cell count, cortisol, and high sensitivity c-reactive protein). S-ketamine had no impact on the expression of biomarkers. Although major differences were observed in biomarker expression between saliva and plasma, the correlations were ultimately limited and weak.

Conclusion:  A single dose of S-ketamine 0.25 mg/kg IV reduces postoperative pain for up to 24h with a longer time to first rescue medication, compared to S -ketamine 0.125 mg/kg and placebo. Single dose S-ketamine 0.25 mg/kg IV gives a minor reduction of SpO2 and a minor increase of pulse rate at the end of infusion of S-ketamine. These changes are clinically insignificant. Third molar surgery causes an immune response within 2 hours expressed in plasma; infusion of S-ketamine 0.25 or 0.125 mg/kg does not cause any immune reaction. The immune response in saliva vs plasma differs and are not interchangeable.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2025. s. 103
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2194
Nyckelord
Pain, Postoperative pain, S-ketamine, Third molar surgery, Efficacy, Safety, Biomarkers, Inflammatory biomarkers, Plasma, Saliva.
Nationell ämneskategori
Anestesi och intensivvård
Identifikatorer
urn:nbn:se:uu:diva-566983 (URN)978-91-513-2621-4 (ISBN)
Disputation
2025-12-03, Bibliotekets föreläsningssal, Falu lasarett, Söderbaums väg 8, Falun, 13:00 (Svenska)
Opponent
Handledare
Tillgänglig från: 2025-11-06 Skapad: 2025-10-09 Senast uppdaterad: 2025-11-06

Open Access i DiVA

fulltext(960 kB)51 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 960 kBChecksumma SHA-512
a8326f5e9ccc5f09311bfba652ccbe110224eaf1eb73c15b074bd5eae930b4d225bc7ca08ec4bbce4200610cf7303f462e82e7a71e94314538dd9dcfbc1528d1
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Person

Eriksson, Lars B.Gordh, TorstenKarlsten, RolfThor, Andreas

Sök vidare i DiVA

Av författaren/redaktören
Eriksson, Lars B.Gordh, TorstenKarlsten, RolfThor, Andreas
Av organisationen
Centrum för klinisk forskning DalarnaInstitutionen för kirurgiska vetenskaperAnestesiologi och intensivvård
Anestesi och intensivvård

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 52 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 354 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf